Oncology Precision Medicine Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Oncology Precision Medicine Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The market for precision oncology has seen swift expansion over recent years. Its value is projected to rise from $125.14 billion in 2025 to $141.22 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.9%. This historical growth has been driven by factors such as restricted access to genomic testing, continued dependence on conventional chemotherapy approaches, a growing incidence of cancer, the early phases of molecular diagnostic advancement, and the implementation of research initiatives focused on oncology within hospital settings.
The oncology precision medicine market is projected to experience significant expansion over the coming years, reaching an estimated value of $226.55 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.5%. This anticipated growth during the forecast period is fueled by progress in CAR-T and gene therapies, the expansion of targeted kinase and immune checkpoint inhibitors, increased funding for precision oncology research, the incorporation of bioinformatics and artificial intelligence into clinical decision-making, and the broadening of biomarker-guided clinical trials. Key trends shaping this period include a growing preference for personalized cancer treatments, heightened utilization of companion diagnostics and molecular diagnostics, the rise of liquid biopsy and next-generation sequencing assays, the proliferation of targeted therapeutics and monoclonal antibodies, and an intensified emphasis on patient stratification based on biomarkers.
Download A Free Sample Report For Comprehensive Market Insights:
#Oncology Precision Medicine Market Growth Factors: Which Forces Are Supporting Market Expansion?
The rising incidence of cancer is anticipated to boost the oncology precision medicine market in the coming period. Cancer is a condition where abnormal cells proliferate without control and may invade other parts of the body, interfering with normal physiological processes. Its increasing frequency is driven by aging populations, as longer lifespans result in the buildup of DNA mutations, weakened repair mechanisms, chronic inflammaging, reduced immune surveillance, and tissue environments that become more favorable for tumor development. In this context, oncology precision medicine proves valuable by delivering tailored therapies that target each tumor’s distinct genetic profile, thereby enhancing treatment efficacy while minimizing adverse effects. By way of illustration, the World Health Organization (WHO), an intergovernmental body based in Switzerland, reported in February 2024 that the estimated 20 million new cancer cases globally in 2022 are projected to surge by 77% to over 35 million cases by 2050. Consequently, the growing prevalence of cancer is fueling expansion in the oncology precision medicine market.
Oncology Precision Medicine Market Segmentation Trends And Revenue Drivers
The oncology precision medicine market covered in this report is segmented –
1) By Product Type: Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs
2) By Technology: Genomics, Proteomics, Bioinformatics, Other Technologies
3) By Biomarker Types: Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types
4) By Applications: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications
5) By End-Users: Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Diagnostics: Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays
2) By Therapeutics: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)
3) By Inhibitor Drugs: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)
4) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies
5) By Cell And Gene Therapy: CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies
6) By Antiviral And Anti-Retroviral Drugs: Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers
Oncology Precision Medicine Market Industry Trends: What Changes Are Reshaping Demand?
Major players in the oncology precision medicine field are actively concentrating on the creation of advanced tools, including molecular tumor board setups, aimed at improving teamwork across disciplines and refining personalized therapy approaches. These boards consist of diverse groups of specialists that assess and decode complex hereditary and molecular information to propose customized cancer management plans. In April 2025, for example, McKesson Corporation, headquartered in the United States and specializing in healthcare services and IT, unveiled the Precision Care Companion project to boost biomarker-focused cancer care via educational resources, technological upgrades, and operational support for oncology clinics. This extensive effort unites medical professionals, clinical teams, business executives, and pharmaceutical collaborators to build a cooperative framework that accelerates the adoption of sophisticated genomic analysis and targeted treatments, ultimately assisting clinicians in providing more tailored and effective cancer care while enhancing patient experiences.
Oncology Precision Medicine Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the oncology precision medicine market are Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc.
Access The Complete Oncology Precision Medicine Market Report:
Oncology Precision Medicine Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the oncology precision medicine market in 2025. The regions covered in the oncology precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
